Cargando…

Desialylation of platelet surface glycans enhances platelet adhesion to adsorbent polymers for lipoprotein apheresis

BACKGROUND: Lipoprotein apheresis is an important therapeutic option in homozygous familial hypercholesterolemia, progressive atherosclerosis, or when depletion of lipoprotein(a) is indicated. It is generally regarded as safe, but drops in platelet counts as well as sporadic episodes of thrombocytop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauková, Lucia, Weiss, René, Semak, Vladislav, Weber, Viktoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524686/ https://www.ncbi.nlm.nih.gov/pubmed/33143534 http://dx.doi.org/10.1177/0391398820968849

Ejemplares similares

Polyzwitterionic Coating of Porous Adsorbents for Therapeutic Apheresis
por: Semak, Vladislav, et al.
Publicado: (2022)

Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones
por: Ebeyer-Masotta, Marie, et al.
Publicado: (2022)

Comparative Analysis of Platelet-Derived Extracellular Vesicles Using Flow Cytometry and Nanoparticle Tracking Analysis
por: George, Sobha Karuthedom, et al.
Publicado: (2021)

Activated Platelets and Platelet-Derived Extracellular Vesicles Mediate COVID-19-Associated Immunothrombosis
por: Ebeyer-Masotta, Marie, et al.
Publicado: (2022)

Desialylation of O-glycans on glycoprotein Ibα drives receptor signaling and platelet clearance
por: Wang, Yingchun, et al.
Publicado: (2020)

Platelet storage induces accelerated desialylation of platelets and increases hepatic thrombopoietin production
por: Cho, Jooyoung, et al.
Publicado: (2018)

Shear Stress Promotes Platelet Surface Desialylation, Platelet Count Drop, and Microvesiculation: Do Platelets Need to be Sugar-Coated?
por: Roka-Moiia, Yana, et al.
Publicado: (2022)

Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan
por: Marini, Irene, et al.
Publicado: (2019)

Platelet desialylation and TFH cells–the novel pathway of immune thrombocytopenia
por: Chen, Yuwen, et al.
Publicado: (2021)

Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia
por: Zheng, Shiying Silvia, et al.
Publicado: (2022)

Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue
por: Riswari, Silvita Fitri, et al.
Publicado: (2019)

CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia
por: Qiu, Jihua, et al.
Publicado: (2016)

Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
por: Tao, Lili, et al.
Publicado: (2017)

New insights into glycoprotein Ibα desialylation-mediated platelet clearance
por: Yule, Jack, et al.
Publicado: (2020)

Association of Platelet Desialylation and Circulating Follicular Helper T Cells in Patients With Thrombocytopenia
por: Chen, Yuwen, et al.
Publicado: (2022)

Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression
por: Li, June, et al.
Publicado: (2023)

Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov
por: Glanz, Victor, et al.
Publicado: (2022)

P1669: AUTOANTIBODY-MEDIATED PLATELET DESIALYLATION IN ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA
por: Schramm, T., et al.
Publicado: (2022)

Kupffer cell receptor CLEC4F is important for the destruction of desialylated platelets in mice
por: Jiang, Yizhi, et al.
Publicado: (2021)

Thromboelastography as a tool for quality check of apheresis platelets
por: Verma, Anupam, et al.
Publicado: (2016)

Cold storage of platelets in additive solution: the impact of residual plasma in apheresis platelet concentrates
por: Marini, Irene, et al.
Publicado: (2019)

Generation of Platelet Microparticles after Cryopreservation of Apheresis Platelet Concentrates Contributes to Hemostatic Activity
por: Eker, İbrahim, et al.
Publicado: (2017)

Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
por: KC, Gayathiri, et al.
Publicado: (2021)

Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
por: Li, June, et al.
Publicado: (2015)

Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT
por: Zhang, Xiao-Hui, et al.
Publicado: (2015)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Current Role of Lipoprotein Apheresis
por: Thompson, Gilbert, et al.
Publicado: (2019)

Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence
por: Dupont, Annabelle, et al.
Publicado: (2019)

Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion
por: Adzahar, Sumaiyah, et al.
Publicado: (2023)

Evaluation of bacterial inactivation in random donor platelets and single-donor apheresis platelets by the INTERCEPT blood system
por: Makroo, Raj Nath, et al.
Publicado: (2018)

Efficacy and Safety of Pathogen-Reduced Platelets Compared with Standard Apheresis Platelets: A Systematic Review of RCTs
por: Pati, Ilaria, et al.
Publicado: (2022)

The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts
por: Lopert, Pamela, et al.
Publicado: (2022)

Apheresis Platelet Rich-Plasma for Regenerative Medicine: An In Vitro Study on Osteogenic Potential
por: Pulcini, Stefano, et al.
Publicado: (2021)

Platelet Desialylation Is a Novel Mechanism and Therapeutic Target in Daboia siamensis and Agkistrodon halys Envenomation-Induced Thrombocytopenia
por: Zhang, Cheng, et al.
Publicado: (2022)

Platelet additive solution suspended apheresis platelets in a tertiary care hospital: A step toward universal single donor platelets
por: Chowdhry, Mohit, et al.
Publicado: (2022)

The argument(s) for lowering the US minimum required content of apheresis platelet components
por: Benjamin, Richard J., et al.
Publicado: (2018)

Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods
por: Singh, Ravindra P., et al.
Publicado: (2009)

Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low‐Density Lipoproteins and Increasing Their Uptake by Macrophages
por: Demina, Ekaterina P., et al.
Publicado: (2021)

Bioactive lipids as biomarkers of adverse reactions associated with apheresis platelet concentrate transfusion
por: Duchez, Anne-Claire, et al.
Publicado: (2023)

Changes in inflammatory responses and autophagy during apheresis platelet preservation and their correlation with platelet transfusion refractoriness in patients with acute lymphoblastic leukemia
por: Li, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pt7iicctvms0ebqlfdqd5h1r4t